☆ 4.4 Article

Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay

MOLECULAR BIOTECHNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein

Subbaian Brindha et al.

Summary: The use of a solubility-enhancing peptide tag containing nine arginine residues can significantly improve the solubility of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein expressed in Escherichia coli. This discovery has the potential to accelerate the development of anti-COVID-19 therapeutics. The folded RBD-C9R demonstrated binding activity with the host cell receptor and elicited a strong immune response in mice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen

Andrey M. Grishin et al.

Summary: The study found that the disulfide bonds of the SARSCoV-2 Spike receptor-binding domain (RBD) play a crucial role in cell receptor binding and viral internalization. Reduction of the four disulfide bonds in the RBD increases flexibility of surface loops, affecting its binding affinity to the ACE2 cell receptor and viral replication.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent

Abdul Basit et al.

Summary: The study introduced a truncated version of human ACE2, tACE2, as a potential therapeutic target for Covid-19. Analysis showed that tACE2 has higher binding affinity for the receptor binding domain of SARS-CoV-2 and forms a more stable complex with it compared to intact ACE2, making it a promising candidate for drug design against Covid-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Microbiology

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection

Sean C. Taylor et al.

Summary: The cPass surrogate virus neutralization test (sVNT) is a highly accurate tool for monitoring SARS-CoV-2 immunity, providing valuable assistance in surveillance of infected/recovered and/or vaccinated individuals, as well as in drug and convalescent-phase donor screening. The data also suggest potential applications for calibrating live-cell neutralization tests and longitudinal testing of recovered and/or vaccinated patients.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

Maria Sinegubova et al.

Summary: The S protein of SARS-CoV-2 is a significant inducer of host immune response due to its unique receptor-binding domain. Researchers developed a technique to produce high-yield SARS-CoV-2 RBD antigen, suitable for serological tests and subunit vaccine studies. This antigen production method ensures the correct folding and glycosylation pattern, allowing for accurate testing and potential vaccine development.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli

Alan Roberto Marquez-Ipina et al.

Summary: Massive serological testing for SARS-CoV-2 is necessary to assess virus exposure, symptomatic versus asymptomatic infections, and post-infection immunity. Researchers successfully produced S-RBDN318-V510 peptide from SARS-CoV-2 spike protein in bacteria for potential cost-effective use in ELISA testing. Results demonstrate the peptide's efficacy as a viable alternative antigen for serological COVID-19 testing.

DIAGNOSTICS (2021)

Add to Collection

Article Chemistry, Analytical

Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells

Christoph Gstottner et al.

Summary: The study provides insights into the structural and functional characteristics of recombinant RBDs expressed in CHO and HEK293 cells, revealing differences in glycosylation patterns. By employing a multilevel mass spectrometric approach, the researchers comprehensively annotated the proteoforms of RBDs, allowing for a detailed analysis of their post-translational modifications. The work not only addressed the binding properties of RBDs to SARS-CoV-2 antibodies and ACE2 receptor, but also established an analytical workflow for characterization and batch-to-batch comparison of new RBDs.

ANALYTICAL CHEMISTRY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli

Yunxia He et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, and the spike protein binds ACE2 to enter host cells. RBD, an important target for virus inhibitors, neutralizing antibodies, and vaccines, can be expressed in E. coli with maintenance of its secondary and tertiary structure. RBD-1 expressed in E. coli has strong binding capabilities to ACE2, potentially useful for vaccine development, drug screening, and virus test kits.

ENGINEERING IN LIFE SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemical Research Methods

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

Kevin R. Bewley et al.

Summary: The protocol from Public Health England discusses the use of three assays to measure neutralizing antibodies against SARS-CoV-2 for assessing COVID-19 vaccine efficacy. The PRNT is considered the gold standard for measuring levels of neutralizing antibodies, while the MNA and PNA offer advantages in terms of assay time, throughput, and operator workload. These assays have been critical in the development and licensure of COVID-19 vaccines and are important for demonstrating bioequivalence of future vaccines.

NATURE PROTOCOLS (2021)

Add to Collection

Article Biochemical Research Methods

An efficient system to generate truncated human angiotensin converting enzyme 2 (hACE2) capable of binding RBD and spike protein of SARS-CoV2

Xiangzheng Gao et al.

Summary: Human angiotensin converting enzyme 2 (hACE2) was cloned, expressed, purified, and evaluated for binding activity in HEK293A cells. The prokaryotic expression system can produce approximately 75 mg of protein per liter, supporting research on infection mechanisms and drug screening for SARS-CoV2.

PROTEIN EXPRESSION AND PURIFICATION (2021)

Add to Collection

Article Biochemical Research Methods

Expression of SARS-CoV-2 surface glycoprotein fragment 319-640 in E. coli, and its refolding and purification

Gabriel A. Fitzgerald et al.

Summary: Sensitive and specific serology tests are crucial for the study of COVID-19, especially in predicting immunity and vaccine-induced immune response through antibody detection. The production method of fragments containing RBD in E. coli shows potential, but the antigenic properties of the resulting product may differ slightly.

PROTEIN EXPRESSION AND PURIFICATION (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The glycosylation in SARS-CoV-2 and its receptor ACE2

Yanqiu Gong et al.

Summary: This article reviews the detection, substrates, biological functions of glycosylation in SARS-CoV-2 proteins, as well as the human receptor ACE2. It also summarizes approved and ongoing SARS-CoV-2 therapeutics associated with glycosylation. This review not only helps broaden the understanding of viral glycobiology, but also provides key clues for the development of new preventive and therapeutic methodologies against SARS-CoV-2 and its variants.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Microbiology

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

James R. Byrnes et al.

MSPHERE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells

Claudia R. Arbeitman et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm

Julie Lobstein et al.

MICROBIAL CELL FACTORIES (2012)

Add to Collection

Article Medicine, Research & Experimental

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology

Jody D. Berry et al.

MABS (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

YX He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.